SKP2 (Ab-64) Antibody 21700 from Signalway Antibody LLC | Biocompare.com

Be the first to write a review!

Supplier Page from
Signalway Antibody LLC for
SKP2 (Ab-64) Antibody

The SKP2 (Ab-64) Antibody from Signalway Antibody LLC is a Rabbit Polyclonal antibody to SKP2. This antibody recognizes Human antigen. The SKP2 (Ab-64) Antibody has been validated for the following applications: Western Blot.

Product Specs
ItemSKP2 (Ab-64) Antibody
CompanySignalway Antibody LLC
Price Pricing Info Supplier Page View Company Product Page
Catalog Number21700
Quantity50ul
ApplicationsWB
Concentration1.0mg/ml
Conjugate/TagUnconjugated
FormatSupplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol
PurityAntibodies were produced by immunizing rabbits with synthetic peptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific peptide
ReactivityHu
Molecular Weight48
HostRabbit
ImmunogenPeptide-KLH
NCBI Full Gene NameS-phase kinase associated protein 2
NCBI Gene AliasesFBXL1, FBL1, p45, FLB1
ClonalityPolyclonal
Domain/Region/TerminusPeptide sequence around aa.62~66 (P-E-S-P-P) derived from Human SKP2
TargetSKP2
ValidationAs per applications, See images, contact for clarifications

Add to Compare List

Signalway Antibody LLC

Signalway Antibody LLC

6305 Ivy Lane, Suite 370

Greenbelt, Maryland 20770

United States

Phone: 1-301-446-2499
Fax: 1-301-446-2413

Email: info@signalwayantibody.com

Company Profile

Website: http://www.sabbiotech.com/

Be the First to Write a Review!

The Magic’s In the Membrane: Choose Wisely for Best Western Blot Results
April 08, 2013
It is important to validate the correct membrane type for your experimental conditions. Choosing the correct membrane type for Western blotting can help prevent transfer inefficiencies, reduce background after staining ... read more

Watch Video: The Immobilon^® Family - a Western story
Western blotting is one of the most commonly used techniques in the lab, yet difficulties persist in... Read More